nach oben

Erschienen in:

01.05.2010 | Original paper

Maternal hormones during early pregnancy: a cross-sectional study

verfasst von: Tianhui Chen, Eva Lundin, Kjell Grankvist, Anne Zeleniuch-Jacquotte, Marianne Wulff, Yelena Afanasyeva, Helena Schock, Robert Johansson, Per Lenner, Goran Hallmans, Goran Wadell, Paolo Toniolo, Annekatrin Lukanova

Erschienen in: Cancer Causes & Control | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Little is known about correlates of first-trimester pregnancy hormones as in most studies maternal hormones have been measured later in gestation. We examined the associations of maternal characteristics and child sex with first-trimester maternal concentrations of four hormones implicated in breast cancer: human chorionic gonadotropin (hCG), α-fetoprotein (AFP), insulin-like growth factor (IGF)-I, and IGF-II.

Methods

About 338 serum samples donated to the Northern Sweden Maternity Cohort (NSMC), 1975–2001, during the first trimester of uncomplicated pregnancies, were analyzed for the hormones of interest as a part of a case–control study. The associations of maternal characteristics and child sex with hormone concentrations were investigated by correlation, general linear regression, and multivariate regression models.

Results

In the first trimester, greater maternal age was inversely correlated with IGF-I and IGF-II. In comparison with women carrying their first child, already parous women had higher IGF-I but lower hCG. Greater maternal weight and smoking were inversely correlated with hCG. No differences in hormone levels by child sex were observed.

Conclusions

Our analyses indicated that potentially modifiable maternal characteristics (maternal weight and smoking) influence first-trimester pregnancy maternal hormone concentrations.

Medina D (2005) Mammary developmental fate and breast cancer risk. Endocr Relat Cancer 12:483–495CrossRefPubMed

Russo IH, Russo J (2007) Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res 174:111–130CrossRefPubMed

Richardson BE, Peck JD, Wormuth JK (2000) Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev 9:1349–1355PubMed

Melbye M, Wohlfahrt J, Lei U et al (2000) Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 92:1001–1005CrossRefPubMed

Lukanova A, Andersson R, Wulff M et al (2008) Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case–control study. Am J Epidemiol 168:1284–1291CrossRefPubMed

Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8:1088–1100CrossRefPubMed

Innes KE, Byers TE (1999) Preeclampsia and breast cancer risk. Epidemiology 10:722–732PubMedCrossRef

Troisi R, Hoover RN, Thadhani R et al (2008) Maternal, prenatal and perinatal characteristics and first trimester maternal serum hormone concentrations. Br J Cancer 99:1161–1164CrossRefPubMed

Kleinberg DL, Feldman M, Ruan W (2000) IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5:7–17CrossRefPubMed

10.

Russo J, Wilgus G, Russo IH (1979) Susceptibility of the mammary gland to carcinogenesis: I differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 96:721–736PubMed

11.

Mullis PE, Tonella P (2008) Regulation of fetal growth: consequences and impact of being born small. Best Pract Res Clin Endocrinol Metab 22:173–190CrossRefPubMed

12.

Garner M, Turner MC, Ghadirian P et al (2008) Testicular cancer and hormonally active agents. J Toxicol Environ Health B Crit Rev 11:260–275PubMed

13.

Lukanova A, Toniolo P, Zeleniuch-Jacquotte A et al (2006) Insulin-like growth factor I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:2489–2493CrossRefPubMed

14.

Speroff L, Fritz M (2005) The endocrinology of pregnancy. In: Speroff L, Fritz M (eds) Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 259–318

15.

Lund PK (1999) Insulin-like growth factors: gene structure and regulation. In: Kostyo JL, Goodman HM (eds) Hormonal control of growth. Oxford University Press, New York, pp 537–571

16.

Chen T, Lukanova A, Kjell G et al. (2009) IGF-I during primiparous pregnancy and maternal risk of breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-009-0519-6 (in press)

17.

Cnattingius S, Ericson A, Gunnarskog J, Kallen B (1990) A quality study of a medical birth registry. Scand J Soc Med 18:143–148PubMed

18.

Cleveland WS, Loader C (1996) Smoothing by local regression: principles and methods. In: Schimek MG (ed) Statistical theory and computational aspects of smoothing. Springer, New York, pp 113–120

19.

Monaghan JM, Godber IM, Lawson N et al (2004) Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy. Ann Clin Biochem 41:220–226CrossRefPubMed

20.

Olajide F, Kitau MJ, Chard T (1989) Maternal serum AFP levels in the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol 30:123–128CrossRefPubMed

21.

Stenman UH, Tiitinen A, Alfthan H, Valmu L (2006) The classification, functions and clinical use of different isoforms of HCG. Hum Reprod Update 12:769–784CrossRefPubMed

22.

Yu H, Mistry J, Nicar MJ et al (1999) Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal 13:166–172CrossRefPubMed

23.

Wald NJ, Watt HC (1996) Serum markers for Down’s syndrome in relation to number of previous births and maternal age. Prenat Diagn 16:699–703CrossRefPubMed

24.

Wald NJ, Kennard A, Hackshaw A, McGuire A (1998) Antenatal screening for Down’s syndrome. Health Technol Assess 2(i–iv):1–112

25.

Arslan AA, Zeleniuch-Jacquotte A, Lukanova A et al (2006) Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev 15:2123–2130CrossRefPubMed

26.

Lukanova A, Toniolo P, Akhmedkhanov A et al (2001) A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 10:443–452CrossRefPubMed

27.

Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD (2005) Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States). Cancer Causes Control 16:917–927CrossRefPubMed

28.

DeLellis K, Rinaldi S, Kaaks RJ et al (2004) Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 13:1444–1451PubMed

29.

Tislaric D, Brajenovic-Milic B, Ristic S et al (2002) The influence of smoking and parity on serum markers for Down’s syndrome screening. Fetal Diagn Ther 17:17–21CrossRefPubMed

30.

de Graaf IM, Cuckle HS, Pajkrt E et al (2000) Co-variables in first trimester maternal serum screening. Prenat Diagn 20:186–189CrossRefPubMed

31.

Canick JA, Lambert-Messerlian GM, Palomaki GE et al (2006) Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol 108:1192–1199PubMed

32.

Voskuil DW, Buenode Mesquita HB, Kaaks R et al (2001) Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1–3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control 12:951–958CrossRefPubMed

33.

Juul A (2003) Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13:113–170CrossRefPubMed

34.

Hunt KJ, Toniolo P, Akhmedkhanov A et al (2002) Insulin-like growth factor II and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 11:901–905PubMed

35.

Walker K, Fletcher O, Johnson N et al (2009) Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 69:6490–6499CrossRefPubMed

36.

Chellakooty M, Vangsgaard K, Larsen T et al (2004) A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 89:384–391CrossRefPubMed

37.

Lambert-Messerlian G, Palomaki GE, Canick JA (2009) Adjustment of serum markers in first trimester screening. J Med Screen 16:102–103CrossRefPubMed

38.

Bestwick JP, Huttly WJ, Wald NJ (2008) First trimester Down’s syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotrophin, pregnancy-associated plasma protein-A and nuchal translucency. J Med Screen 15:204–206CrossRefPubMed

39.

Crossley JA, Aitken DA, Waugh SM, Kelly T, Connor JM (2002) Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening. Prenat Diagn 22:247–255CrossRefPubMed

40.

Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK (2002) Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Prenat Diagn 22:893–897CrossRefPubMed

41.

Ermis B, Altinkaynak K, Yildirim A, Ozkan B (2004) Influence of smoking on serum and milk of mothers, and their infants’ serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels. Horm Res 62:288–292CrossRefPubMed

42.

Allen NE, Appleby PN, Kaaks R et al (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14:65–74CrossRefPubMed

43.

Yaron Y, Lehavi O, Orr-Urtreger A et al (2002) Maternal serum HCG is higher in the presence of a female fetus as early as week 3 post-fertilization. Hum Reprod 17:485–489CrossRefPubMed

44.

Yaron Y, Wolman I, Kupferminc MJ et al (2001) Effect of fetal gender on first trimester markers and on Down syndrome screening. Prenat Diagn 21:1027–1030CrossRefPubMed

45.

Larsen SO, Wojdemann KR, Shalmi AC et al (2002) Gender impact on first trimester markers in Down syndrome screening. Prenat Diagn 22:1207–1208CrossRefPubMed

46.

Mueller VM, Huang T, Summers AM, Winsor SH (2005) The effect of fetal gender on the false-positive rate of Down syndrome by maternal serum screening. Prenat Diagn 25:1258–1261CrossRefPubMed

47.

Spencer K (2000) The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free beta-hCG. Prenat Diagn 20:648–651CrossRefPubMed

48.

Caufriez A, Frankenne F, Hennen G, Copinschi G (1993) Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 265:E572–E577PubMed

49.

Vatten LJ, Nilsen ST, Odegard RA, Romundstad PR, Austgulen R (2002) Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 109:1131–1135CrossRefPubMed

50.

Ibanez L, Sebastiani G, Lopez-Bermejo A et al (2008) Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J Clin Endocrinol Metab 93:2774–2778CrossRefPubMed

51.

Engstrom E, Niklasson A, Wikland KA, Ewald U, Hellstrom A (2005) The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res 57:605–610CrossRefPubMed

52.

Lagiou P, Hsieh CC, Lipworth L et al (2009) Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer 100:1794–1798CrossRefPubMed

53.

Sivaraman L, Medina D (2002) Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 7:77–92CrossRefPubMed

54.

Zhang Y, Graubard BI, Klebanoff MA et al (2005) Maternal hormone levels among populations at high and low risk of testicular germ cell cancer. Br J Cancer 92:1787–1793CrossRefPubMed

55.

Bernstein L, Lipworth L, Ross RK, Trichopoulos D (1995) Correlation of estrogen levels between successive pregnancies. Am J Epidemiol 142:625–628PubMed

56.

Wald NJ, Huttly WJ, Rudnicka AR (2004) Prenatal screening for Down syndrome: the problem of recurrent false-positives. Prenat Diagn 24:389–392CrossRefPubMed

57.

de Medeiros SF, Norman RJ (2009) Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights. Hum Reprod Update 15:69–95CrossRefPubMed

58.

Russo J, Russo IH (1995) Hormonally induced differentiation: a novel approach to breast cancer prevention. J Cell Biochem Suppl 22:58–64CrossRefPubMed

59.

Kappel B, Hansen K, Moller J, Faaborg-Andersen J (1985) Human placental lactogen and dU-estrogen levels in normal twin pregnancies. Acta Genet Med Gemellol (Roma) 34:59–65

60.

Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK (1995) Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 4:437–440PubMed

61.

Kinnunen TI, Luoto R, Gissler M, Hemminki E, Hilakivi-Clarke L (2004) Pregnancy weight gain and breast cancer risk. BMC Womens Health 4:7CrossRefPubMed

62.

Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133–140CrossRefPubMed

63.

Fink AK, Lash TL (2003) A null association between smoking during pregnancy and breast cancer using Massachusetts registry data (United States). Cancer Causes Control 14:497–503CrossRefPubMed

64.

Terry PD, Rohan TE (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11:953–971PubMed

65.

Gram IT, Braaten T, Terry PD et al (2005) Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14:61–66PubMed

66.

Ishibe N, Hankinson SE, Colditz GA et al (1998) Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses’ health study. Cancer Res 58:667–671PubMed

Titel: Maternal hormones during early pregnancy: a cross-sectional study
verfasst von: Tianhui Chen
Eva Lundin
Kjell Grankvist
Anne Zeleniuch-Jacquotte
Marianne Wulff
Yelena Afanasyeva
Helena Schock
Robert Johansson
Per Lenner
Goran Hallmans
Goran Wadell
Paolo Toniolo
Annekatrin Lukanova
Publikationsdatum: 01.05.2010
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 5/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-009-9500-2

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Maternal hormones during early pregnancy: a cross-sectional study

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2010

Ensuring long-term sustainability of existing cohorts remains the highest priority to inform cancer prevention and control

Risk factors for lung cancer: a case–control study in Hong Kong women

Defining research priorities for pancreatic cancer in Australia: results of a consensus development process

Parkinson’s disease and cancer risk: a systematic review and meta-analysis

Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case–control study in Michigan, USA

Human papillomavirus is not associated with colorectal cancer in a large international study

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie